Andrey Zarur, GreenLight Biosciences CEO

Green­Light Bio­sciences se­cures merg­er as it looks to go pri­vate

Green­Light Bio­science, the de­vel­op­er and man­u­fac­tur­er of RNA vac­cines and ther­a­peu­tics, is set to be ac­quired.

The com­pa­ny an­nounced ear­li­er this …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.